Skip to main content
. 2019 Sep 25;60(6):812–817. doi: 10.1093/jrr/rrz060

Table 2.

Characteristics of the patients who experienced abnormal olfactory sensations during radiation treatment

Sex/age (years) Primary disease/location Surgery/Biopsy Radiation therapy First day recorded (treatment days/cumulative dose (Gy)) D2 of the olfactory region (Gy)a Counter measure
CTV Technique Dose/fraction (Gy)
1 F/17 GCT hypothalamus Craniotomy and biopsy CSI Conventional 1.8 3/5.4 1.8 Stuff up the nose
2 F/8 GCT pineal body Craniotomy and biopsy WV 3D-CRT 2.0 3/6.0 1.3 None
3 M/12 GCT pineal body Endoscopic biopsy WV 3D-CRT 1.8 11/14.4 0.74 Essential oils
4 M/13 Ependymoma temporal lobe Craniotomy and tumorectomy LF IMRT 1.8 23/30.6 1.1 Essential oils
5 M/47 Pituitary A Pituitary G Tumorectomy through the nose LF IMRT 1.8 8/10.8 1.8 None
6 M/14 GCT pineal body Endoscopic biopsy WV IMRT 1.8 20/27 1.3 Essential oils
7 M/11 Ependymoma posterior fossa Craniotomy and tumorectomy LF IMRT 1.8 12/14.4 0.50 Sedation

aGy/fraction. M = male, F = female, GCT = germ cell tumor, pituitary A = pituitary adenoma, pituitary G = pituitary gland, CSI = craniospinal irradiation, WV = whole ventricle, LF = localized field, 3D-CRT = 3D conformal radiation therapy, IMRT = intensity-modulated radiation therapy.